PCH
BIOA

Polar Capital Holdings’s BioAge Labs BIOA Stock Holding History

Polar Capital Holdings’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.3M Sell
1,072,344
-60,296
-5% -$1.09M 0.06% 157
2026
Q1 		$19.8M Buy
+1,132,640
New +$21.8M 0.07% 147

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Polar Capital Holdings's BIOA Position: Q2 2026 in Review

Polar Capital Holdings reduced its BioAge Labs (BIOA) stake by 5.3% in Q2 2026, selling an estimated $1.09M and leaving 1,072,344 shares worth $26.3M. The position accounts for 0.06% of the portfolio, ranked #157.

Polar Capital Holdings first reported a position in BIOA in Q1 2026 and has held it in 2 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Polar Capital Holdings held 1,072,344 shares of BioAge Labs worth $26.3M as of Q2 2026.
  • Polar Capital Holdings sold 60,296 BioAge Labs shares in Q2 2026, an estimated $1.09M.
  • BioAge Labs made up 0.06% of Polar Capital Holdings's portfolio in Q2 2026, its #157 holding.
  • Polar Capital Holdings first reported a position in BioAge Labs in Q1 2026 and has held it in 2 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.